CEACAM1 Antikörper

Produktnummer ABIN114594

Produktdetails anti-CEACAM1 Antikörper

Target: CEACAM1 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1))

Reaktivität: Human, Säugetier

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CEACAM1 Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)

Spezifität: This antibody detects complete native protein expressed on transfected cells.

Aufreinigung: Protein G Chromatography

Immunogen: Genetic immunisation with cDNA encoding the extracellular region of Human CEACAM1-A2. Based on recognition of the complete native protein expressed on transfected mammalian cells.

Klon: 8G5

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Flow cytometry: 1.2 μg/10^6 cellsCompetitive ELISA: 1: 200 - 1: 400. ELISA: 1: 200 - 1: 400. Immunoflourescence. Immunohistology: 10 μg/mL (on cryosections).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS, pH 7.2

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the reconstituted antibody at 2-8 °C for one month (add 0.09% Sodium Azide) or at -20 °C for longer.

Referenzen für anti-CEACAM1 Antikörper (ABIN114594)

Peng, Oberst, Huang, Brohawn, Morehouse, Lekstrom, Baeuerle, Wu, Yao, Coats, DallAcqua, Damschroder, Hammond: "The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA." in: PLoS ONE, Vol. 7, Issue 5, pp. e36412, (2012) (PubMed).

Sémiramoth, Gleizes, Turbica, Sandré, Gorges, Kansau, Servin, Chollet-Martin: "Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism." in: Journal of leukocyte biology, Vol. 85, Issue 2, pp. 310-21, (2009) (PubMed).

Béaslas, Torreilles, Casellas, Simon, Fabre, Lacasa, Delers, Chambaz, Rousset, Carrière: "Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes." in: American journal of physiology. Gastrointestinal and liver physiology, Vol. 295, Issue 5, pp. G942-52, (2008) (PubMed).

Nittka, Böhm, Zentgraf, Neumaier: "The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1." in: Oncogene, Vol. 27, Issue 26, pp. 3721-8, (2008) (PubMed).

Thomas, Zhu, Schnaar, Alves, Konstantopoulos: "Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow." in: The Journal of biological chemistry, Vol. 283, Issue 23, pp. 15647-55, (2008) (PubMed).

Yoon, Terada, Kita: "CD66b regulates adhesion and activation of human eosinophils." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 12, pp. 8454-62, (2007) (PubMed).

Avadhanula, Rodriguez, Devincenzo, Wang, Webby, Ulett, Adderson: "Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner." in: Journal of virology, Vol. 80, Issue 4, pp. 1629-36, (2006) (PubMed).

Kammerer, Riesenberg, Weiler, Lohrmann, Schleypen, Zimmermann: "The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma." in: The Journal of pathology, Vol. 204, Issue 3, pp. 258-67, (2004) (PubMed).

Details zu CEACAM1

Target: CEACAM1 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1))

Andere Bezeichnung: CD66a / CEACAM1 (CEACAM1 Produkte)

Synonyme: BGP antikoerper, BGP1 antikoerper, BGPI antikoerper, CD66e antikoerper, CEA antikoerper, zeh0068 antikoerper, hm:zeh0068 antikoerper, CEACAM8 antikoerper, CEACAM1 antikoerper, MGC142545 antikoerper, BGPR antikoerper, Bgp antikoerper, CD66a antikoerper, Ccam1 antikoerper, Bgp1 antikoerper, C-CAM antikoerper, Cc1 antikoerper, Cea-1 antikoerper, Cea-7 antikoerper, Cea1 antikoerper, Cea7 antikoerper, Hv-2 antikoerper, Hv2 antikoerper, MHVR antikoerper, MHVR1 antikoerper, Mhv-1 antikoerper, bb-1 antikoerper, mCEA1 antikoerper, mmCGM1 antikoerper, mmCGM1a antikoerper, mmCGM2 antikoerper, carcinoembryonic antigen related cell adhesion molecule 1 antikoerper, carcinoembryonic antigen related cell adhesion molecule 5 antikoerper, carcinoembryonic antigen-related cell adhesion molecule 1 antikoerper, carcinoembryonic antigen-related cell adhesion molecule 6 antikoerper, CEACAM1 antikoerper, CEACAM5 antikoerper, ceacam1 antikoerper, Ceacam1 antikoerper, LOC101103343 antikoerper

Hintergrund: CEACAM1 (BGP/CD66a) is a transmembrane glycoprotein which belongs to the carcinoembryonic antigen (CEA) gene family (1,2). It is expressed on cells of epithelial and myeloid origin and mediates homophilic intercellular interactions that influence cellular growth, immune cell activation, and tissue morphogenesis. CEACAM1 is a putative tumour suppressor based on diminished expression in some aggressive types of cancer cells (3). The anti-tumour effect may be due to inhibition of tumour angiogenesis, possibly by increased secretion of anti-angiogenic molecules from the cells (4). Like all members of the CEACAM family, it consists of a single N domain, with structural homology to the immunoglobulin variable domains, followed by two immunoglobulin constant-like A (A1, A2) and one B domain. While the N, A1 and B domains can also be found in other CEA-family members, the A2 domain of CEACAM1 differs from those found in other CEACAM.Synonyms: BGP, BGP1, Biliary glycoprotein 1, Carcinoembryonic antigen-related cell adhesion molecule 1

Gen-ID: 634

NCBI Accession: NP_001020083

UniProt: P13688